CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-30 | Bancroft Charles A Director | Grant or award · Stock Option (Right to Buy) | +2,104 | 2,104 | ||
| 2020-06-30 | EHRLICH JASON See Remarks | Grant or award · Stock Option (Right to Buy) | +46,163 | 46,163 | ||
| 2020-06-30 | EHRLICH JASON See Remarks | Grant or award · Restricted Stock Units | +14,476 | 14,476 | ||
| 2020-06-30 | BORGESON JOHN A. See Remarks | Grant or award · Stock Option (Right to Buy) | +46,163 | 46,163 | ||
| 2020-06-30 | BORGESON JOHN A. See Remarks | Grant or award · Restricted Stock Units | +14,476 | 14,476 | ||
| 2020-06-30 | PERLROTH VICTOR Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +247,498 | 247,498 | ||
| 2020-06-22 | EHRLICH JASON See Remarks | Option exercise | +6,950 | $10.29 | $72K | 38,234 |
| 2020-06-22 | EHRLICH JASON See Remarks | Sale | −2,792 | $59.35 | $166K | 35,442 |
| 2020-06-22 | EHRLICH JASON See Remarks | Sale | −1,684 | $60.33 | $102K | 33,758 |
| 2020-06-22 | EHRLICH JASON See Remarks | Sale | −1,645 | $61.49 | $101K | 32,113 |
| 2020-06-22 | EHRLICH JASON See Remarks | Sale | −723 | $62.92 | $45K | 31,390 |
| 2020-06-22 | EHRLICH JASON See Remarks | Sale | −106 | $64.08 | $7K | 31,284 |
| 2020-06-22 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | −6,950 | 396,125 | ||
| 2020-06-08 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +4,135 | 4,135 | ||
| 2020-06-08 | PROFUSEK ROBERT Director | Grant or award · Stock Option (Right to Buy) | +4,135 | 4,135 | ||
| 2020-06-08 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +4,135 | 4,135 | ||
| 2020-06-08 | Dahiyat Bassil I Director | Grant or award · Stock Option (Right to Buy) | +4,135 | 4,135 | ||
| 2020-05-20 | EHRLICH JASON See Remarks | Option exercise | +6,950 | $10.29 | $72K | 38,234 |
| 2020-05-20 | EHRLICH JASON See Remarks | Sale | −1,229 | $59.36 | $73K | 37,005 |
| 2020-05-20 | EHRLICH JASON See Remarks | Sale | −3,631 | $60.61 | $220K | 33,374 |
Page 30 of 37 · 722 trades